{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "Food and Drug Administration permits resumption of experimental trial for leukemia treatment by Juno Therapeutics, after modification; two patients had perished from brain swelling. ", "type_of_material": "News", "word_count": "195", "lead_paragraph": "The government said two deaths that prompted it to stop the study had been caused by a drug used in pretreatment, not the leukemia treatment.", "pub_date": "2016-07-13T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Study of Juno Therapeutics Leukemia Treatment Is Allowed to Resume", "print_headline": "F.D.A. Allows Resumption  of a Leukemia Drug Trial"}, "snippet": "The government said two deaths that prompted it to stop the study had been caused by a drug used in pretreatment, not the leukemia treatment....", "multimedia": [], "web_url": "http://www.nytimes.com/2016/07/13/business/study-of-juno-therapeutics-leukemia-treatment-is-allowed-to-resume.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Leukemia", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Cancer", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Juno Therapeutics Inc", "name": "organizations"}], "blog": [], "_id": "578586c438f0d804dfd9ba01", "source": "The New York Times"}